InnoCan Pharma's total assets for Q2 2025 were $11.04M, an increase of 2.03% from the previous quarter. TSE:INNO total liabilities were $4.35M for the fiscal quarter, a 10.66% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.